How Much Did IndyGeneUS AI Raise?
Funding & Key Investors

IndyGeneUS AI has successfully secured a significant capital injection, marking a pivotal moment in its corporate trajectory. With a total funding amount reaching $2M, the firm is well-positioned to accelerate its mission of democratizing genomic insights. This recent funding amount of $2M serves as a major strategic investment, enabling the company to scale its proprietary infrastructure and expand its reach within the competitive biotechnology landscape.

What is IndyGeneUS AI?

IndyGeneUS AI
Business ServicesResearch & DevelopmentHealthcare Software

IndyGeneUS AI operates as a specialized Service-Disabled Veteran-Owned Small Business (SDVOSB) at the intersection of genomics, blockchain technology, and clinical research. The company is architecting the world's largest digital, blockchain-encrypted repository specifically focused on indigenous and diasporic African clinical and genomic data. By synthesizing multi-omics data with electronic healthcare records and vast textual scientific manuscripts, the firm identifies novel signature sequences and polygenic risk scores. This unique value proposition addresses critical gaps in global genomic datasets, ensuring that underrepresented populations are accurately reflected in the future of precision medicine and personalized healthcare diagnostics.

How much funding has IndyGeneUS AI raised?

IndyGeneUS AI has raised a total of $2M across 1 funding round:

2021

Angel/Seed

$2M

Angel/Seed (2021): $2M, investors not publicly disclosed

Key Investors in IndyGeneUS AI

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for IndyGeneUS AI?

Following this major enterprise-level funding, IndyGeneUS AI is poised to transition from its foundational development phase into a period of aggressive operational scaling. The strategic roadmap likely involves enhancing the computational power of its proprietary AI engines to process increasingly complex multi-omics datasets. Furthermore, the company is expected to forge deeper partnerships with clinical research organizations and pharmaceutical entities that require high-fidelity, diverse genomic data to drive drug discovery and therapeutic innovation. By leveraging its secure blockchain framework, IndyGeneUS AI will likely focus on establishing industry standards for data sovereignty and ethical genomic research, solidifying its role as a critical infrastructure provider in the global health-tech ecosystem.

See full IndyGeneUS AI company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Accounting for Legal PracticesBusiness Services
Business ServicesSoftware Testing
Business ServicesHuman Resources Management Systems (HRMS)
Business ServicesResearch & Development

Frequently Asked Questions Regarding IndyGeneUS AI Financial Insights

What are the most recent funding rounds that IndyGeneUS AI has completed, and what were the funding rounds?
IndyGeneUS AI has recently completed 1 funding rounds: Angel/Seed on Dec 27, 2021.
What is the total amount of funding IndyGeneUS AI has raised to date?
IndyGeneUS AI has raised a total of $2M in funding to date.
How many funding rounds has IndyGeneUS AI completed?
IndyGeneUS AI has completed 1 funding rounds.
How much funding did IndyGeneUS AI raise in its most recent funding round?
IndyGeneUS AI raised $2M in its most recent funding round.
Which was the largest funding round in IndyGeneUS AI's history?
The largest funding round in IndyGeneUS AI's history was $2M.
See more information about IndyGeneUS AI